EDIT:NASDAQ
Editas Medicine Inc
2,49 US$
arrow_downward
-0,80%(-0,020) 1K
2,47 US$
arrow_downward
-0,67% (-0,017)bedtimeYopilgandan keyin
Savdolar yopilgan: 22-okt, 16:00:01 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoEDIT tikeri uchun statistika yaratilmoqda...
Ochish
2,47 US$
Yuqori
2,58 US$
Past
2,45 US$
Bozor kapitali
382,41 mln
Oʻrtacha hajm
2,97 mln
Hajmi
0,00
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,74 US$
Beta
2,00
Muomaladagi aksiyalar
153,58 mln
Xodimlar soni
87
Ochish
2,47 US$
Yuqori
2,58 US$
Past
2,45 US$
Bozor kapitali
382,41 mln
Oʻrtacha hajm
2,97 mln
Hajmi
0,00
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,74 US$
Beta
2,00
Muomaladagi aksiyalar
153,58 mln
Xodimlar soni
87
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Yahoo Finance
·
20 daqiqa oldin
Stock Market: Will S&P 500 Open Up or Down Today?
Investing.com
·
22 daqiqa oldin
Nasdaq, Treasury Yields and US Dollar Face a Major AI Sentiment Test
CryptoTicker
·
40 daqiqa oldin
Bitcoin price $81,568 after $431m liquidations
CBS News
·
10 soat oldin
Nasdaq dives more than 750 points as investors worry massive AI spending won't pay off
Profil
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
Editas Medicine Inc haqida